New Developments in the Prevention of Intravascular Catheter Associated Infections

Infectious Disease Clinics of North America

Volumn 26, Issue 1, 2012, Pages 1-11

  Hewlett, Angela L ^a   Rupp, Mark E ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bloodstream infection; Catheter related bloodstream infection; Central venous catheter; Intravascular catheter

Indexed keywords

CHLORHEXIDINE; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE SILVER;

BACTERIUM CONTAMINATION; CATHETER INFECTION; CLINICAL EFFECTIVENESS; CONCENTRATION (PARAMETERS); COST OF ILLNESS; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; GOOD CLINICAL PRACTICE; HIGH RISK PATIENT; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTRAVASCULAR CATHETER; MATERIAL COATING; MEDICAL TECHNOLOGY; NONHUMAN; PATHOGENESIS; PATIENT SAFETY; REVIEW; RISK REDUCTION; SKIN DECONTAMINATION; STAPHYLOCOCCUS AUREUS; TOTAL QUALITY MANAGEMENT; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84856271020     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2011.09.002     Document Type: Review

References (44)

1. Weber D.J., Rutala W.A. Central line-associated bloodstream infections: prevention and management. Infect Dis Clin North Am 2011, 25(1):77-102.
2. Edwards J.R., Peterson K.D., Banerjee S., et al. National Healthcare Safety Network (NHSN) report: data for 2006 through 2008, issued December 2009. Am J Infect Control 2009, 37:783-805.
3. O'Grady N.P., Alexander M., Burns L.A., et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011, 52(9):e162-e193.
4. Centers for Disease Control and Prevention (CDC) Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011, 60(8):243-248.
5. Yanagi H., Sherertz R.J. Infections of intravascular catheters and vascular devices. Staphylococci in human disease 2009, 363-377. Wiley-Blackwell, Chichester, West Sussex. 2nd edition. K.B. Crossley, K.K. Jefferson, G. Archer (Eds.).
6. Petri W.A., Mann B.J., Huston C.D. Microbial adherence. Principles and practice of infectious diseases' 2009, 15-25. Churchill Livingstone Elsevier, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R.G. Douglas (Eds.).
7. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-193.
8. Fey P.D., Olson M.E. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol 2010, 5:917-933.
9. Lewis K., Spoering A.L., Kaldalu N., et al. Persiters: specialized cells responsible for biofilm tolerance. Biofilms, infection, and antimicrobial therapy 2006, 241-256. Taylor & Francis, Boca Raton (FL). J.L. Pace, M.E. Rupp, R.G. Finch (Eds.).
10. Mermel L.A., Allon M., Bouza E., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis 2009, 49:1-45.
11. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002, 23(12):759-769.
12. Centers for Disease Control and Prevention (CDC) Reduction in central line-associated bloodstream infections among patients in intensive care units-Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005, 54(40):1013-1016.
13. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. NEngl J Med 2006, 355(26):2725-2732.
14. Pronovost P.J., Goeschel C.A., Colantuoni E., et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 2010, 340:c309.
15. Lipitz-Snyderman A., Steinwachs D., Needham D.M., et al. Impact of a statewide intensive care unit quality improvement initiative on hospital mortality and length of stay: retrospective comparative analysis. BMJ 2011, 342:d219.
16. Fridkin S.K., Pear S.M., Williamson T.H., et al. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996, 17(3):150-158.
17. Froehlich C.D., Rigby M.R., Rosenberg E.S., et al. Ultrasound-guided central venous catheter placement decreases complications and decreases placement attempts compared with the landmark technique in patients in a pediatric intensive care unit. Crit Care Med 2009, 37(3):1090-1096.
18. Hind D., Calvert N., McWilliams R., et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003, 327(7411):361.
19. Randolph A.G., Cook D.J., Gonzales C.A., et al. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med 1996, 24(12):2053-2058.
20. Fragou M., Gravvanis A., Dimitriou V., et al. Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: a prospective randomized study. Crit Care Med 2011, 39(7):1607-1612.
21. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002, 136(11):792-801.
22. Bryant K.A., Zerr D.M., Huskins W.C., et al. The past, present, and future of healthcare-associated infection prevention in pediatrics: catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 2010, 31(Suppl 1):S27-S31.
23. Ruschulte H., Franke M., Gastmeier P., et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 2009, 88(3):267-272.
24. Timsit J.F., Schwebel C., Bouadma L., et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009, 301(12):1231-1241.
25. Veenstra D.L., Saint S., Saha S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999, 281:261-267.
26. Darouiche R.O., Raad I.I., Heard S.O., et al. Acomparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. NEngl J Med 1999, 340:1-8.
27. Raad I., Darouiche R., Dupuis J., et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997, 127:267-274.
28. Ramos E.R., Reitzel R., Jiang Y., et al. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med 2011, 39(2):245-251.
29. Cober M.P. Ethanol-lock therapy for the prevention of central venous access device infections in pediatric patients with intestinal failure. JPEN J Parenter Enteral Nutr 2011, 35(1):67.
30. Hemmelgarn B.R. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. NEngl J Med 2011, 364(4):303.
31. Sanders J. Aprospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. JAntimicrob Chemother 2008, 62(4):809.
32. Maki D.G., Ash S.R., Winger R.K., et al. Anovel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med 2011, 39(4):613.
33. Bleasdale S.C. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007, 167(19):2073.
34. Popovich K.J. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009, 30(10):959.
35. Munoz-Price L.S. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009, 30(11):1031.
36. Kassakian S.Z., Mermel L.A., Jefferson J.A., et al. Impact of chlorhexidine bathing on hospital-acquired infections among general medical patients. Infect Control Hosp Epidemiol 2011, 32(3):238-243.
37. Salgado C.D., Chinnes L., Paczesny T.H., et al. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infect Control Hosp Epidemiol 2007, 28(6):684-688.
38. Jarvis W.R., Murphy C., Hall K.K., et al. Health care-associated bloodstream infections associated with negative- or positive-pressure or displacement mechanical valve needleless connectors. Clin Infect Dis 2009, 49(12):1821-1827.
39. Rupp M.E., Sholtz L.A., Jourdan D.R., et al. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis 2007, 44(11):1408-1414.
40. Maki D.G. Invitro studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection. Clin Infect Dis 2010, 50(12):1580.
41. Yamamoto A.J., Solomon J.A., Soulen M.C., et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. JVasc Interv Radiol 2002, 13(1):77-81.
42. Centers for Medicare and Medicaid Services. Hospital-acquired conditions. Available at: Accessed April 25, 2011. http://www.cms.gov/HospitalAcqCond/06_Hospital-Acquired_Conditions.asp.
43. McKibben L., Horan T., Tokars J.I., et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control 2005, 33(4):217-226.
44. Safdar N., Maki D.G. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest 2005, 128(2):489-495.